ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Suliqua 100/33, solution injectable - 3
66283003 Sanofi-Aventis (Suisse) SA
Suliqua 100/33, solution injectable05.10.2017
  05.10.2017
Insulins and Analogues for Injection, Long-Acting (A10AE) 
WHO-DDD 
07.06.3
07.06. 
B  
Yes 
IPCI
67.84Yes
    
10 %90.20
  
7680662830035Biotechnologika
7298959 
Composition
insulinum glarginum 3.6378 mg corresp. insulinum glarginum 100 U., lixisenatidum 0.033 mg, glycerolum (85 per centum), methioninum, metacresolum, zinci chloridum, acidum hydrochloridum concentratum, natrii hydroxidum corresp. natrium max. 0.06 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
Packungsbestandteile
Injection solution 
  
 
Active AgentDose
Insulin Glargine3.6378 mg/ml correspond Insulin Glargine 100 U/ml
Lixisenatidum0.033 mg/ml
BAG: Active AgentDose
Insulin Glargine100 U
Lixisenatidum0.033 mg
 
Inactive agents
Acidum Hydrochloridum Concentratum
Glycerol
Metacresol
Methionine
Sodium Hydroxide
Zinc Chlorideate
 
Source
Data was imported : 05.03.2026 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2026 ©ywesee GmbH
Settings | Help | Login | Contact | Home